Neogen Co. (NASDAQ:NEOG) CFO Buys $156,375.00 in Stock

Neogen Co. (NASDAQ:NEOG - Get Free Report) CFO David H. Naemura acquired 12,500 shares of the company's stock in a transaction dated Wednesday, April 10th. The shares were bought at an average price of $12.51 per share, for a total transaction of $156,375.00. Following the acquisition, the chief financial officer now directly owns 30,040 shares of the company's stock, valued at approximately $375,800.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Neogen Stock Down 4.1 %

Neogen stock opened at $12.50 on Thursday. The firm has a market capitalization of $2.71 billion, a price-to-earnings ratio of 208.37 and a beta of 1.13. The firm's fifty day moving average price is $15.92 and its two-hundred day moving average price is $16.80. Neogen Co. has a 1-year low of $12.18 and a 1-year high of $24.09. The company has a current ratio of 3.54, a quick ratio of 2.63 and a debt-to-equity ratio of 0.28.

Neogen (NASDAQ:NEOG - Get Free Report) last released its quarterly earnings results on Tuesday, April 9th. The company reported $0.12 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.14 by ($0.02). The company had revenue of $228.80 million for the quarter, compared to analyst estimates of $230.01 million. Neogen had a net margin of 1.28% and a return on equity of 3.35%. Neogen's revenue for the quarter was up 4.8% on a year-over-year basis. During the same quarter last year, the firm posted $0.12 EPS. On average, equities research analysts predict that Neogen Co. will post 0.54 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In


Nvidia CEO Says It Will Be “the Next Revolution” Beyond AI
Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.
Click on Adam's shiny forehead for more details.


Separately, Piper Sandler upped their price target on Neogen from $17.50 to $19.00 and gave the stock a "neutral" rating in a research note on Thursday, January 18th.

Get Our Latest Analysis on NEOG

Institutional Trading of Neogen

Institutional investors have recently made changes to their positions in the company. BlackRock Inc. purchased a new position in Neogen during the first quarter worth about $451,277,000. Norges Bank bought a new position in shares of Neogen in the fourth quarter valued at approximately $365,794,000. Baillie Gifford & Co. purchased a new stake in shares of Neogen during the fourth quarter valued at approximately $166,646,000. Select Equity Group L.P. bought a new stake in Neogen during the first quarter worth $147,849,000. Finally, Geode Capital Management LLC purchased a new position in Neogen in the first quarter worth $84,319,000. Institutional investors own 96.73% of the company's stock.

Neogen Company Profile

(Get Free Report)

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, genetic modifications, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns; and AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods.

Featured Stories

Insider Buying and Selling by Quarter for Neogen (NASDAQ:NEOG)

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at Neogen?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Neogen and related companies.
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.

Most Read This Month

Recent Articles